NCT00074529View on ClinicalTrials.gov

Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

512

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Alzheimer's Disease
Interventions
DRUG

MK0677

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00074529 - Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) | Biotech Hunter | Biotech Hunter